Literature DB >> 137301

Levodopa and Huntington's chorea.

C Loeb, G Roccatagliata, G La Medica, G Abbruzzese, C Albano.   

Abstract

Two patients with Huntington's chorea are reported whose psychiatric and neurological symptoms greatly improved after treatment with L-dopa. In both cases the basal values of CSF HVA were markedly decreased, being increased by the treatment with L-dopa.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 137301      PMCID： PMC492498          DOI： 10.1136/jnnp.39.10.958

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  19 in total

1.  HVA and 5HIAA CSF measurements and 5HTP trials in some patients with involuntary movements.

Authors:  C Guilleminault; B R Tharp; D Cousin
Journal:  J Neurol Sci       Date:  1973-04       Impact factor: 3.181

2.  Cholinergic and dopaminergic mechanisms in Huntington's chorea.

Authors:  S M Aquilonius; R Sjöström
Journal:  Life Sci I       Date:  1971-04-01

Review 3.  The importance of monoamine metabolism for the pathology of the extrapyramidal system.

Authors:  W Birkmayer
Journal:  J Neurovisc Relat       Date:  1969

4.  [Homovanillic acid in the cerebrospinal fluid: studies in Parkinson's syndrome and other diseases of the CNS].

Authors:  H Bernheimer; W Birkmayer; O Hornykiewicz
Journal:  Wien Klin Wochenschr       Date:  1966-06-10       Impact factor: 1.704

5.  Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.

Authors:  H Bernheimer; W Birkmayer; O Hornykiewicz; K Jellinger; F Seitelberger
Journal:  J Neurol Sci       Date:  1973-12       Impact factor: 3.181

6.  Apomorphine, pimozide, L-Dopa and the probenecid test in Huntington's chorea.

Authors:  S Lal; C De la Vega; E Garelis; T L Sourkes
Journal:  Psychiatr Neurol Neurochir       Date:  1973 Mar-Apr

7.  Amine metabolites in the cerbrospinal fluid in Huntington's chorea.

Authors:  G Curzon; J Gumpert; D Sharpe
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-08       Impact factor: 10.154

8.  A pharmacologic analysis of Huntington's chorea.

Authors:  H L Klawans
Journal:  Eur Neurol       Date:  1970       Impact factor: 1.710

9.  Cerebrospinal fluid homovanillic acid in Huntington's chorea.

Authors:  H L Klawans
Journal:  J Neurol Sci       Date:  1971-07       Impact factor: 3.181

10.  Modification of Parkinsonism--chronic treatment with L-dopa.

Authors:  G C Cotzias; P S Papavasiliou; R Gellene
Journal:  N Engl J Med       Date:  1969-02-13       Impact factor: 91.245
View more
  3 in total

1.  Homovanilic acid in Huntington's disease and Sydenham's chorea.

Authors:  L Cunha; C R Oliveira; M Diniz; R Amaral; A F Conçalves; J Pio-Abreu
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-03       Impact factor: 10.154

Review 2.  Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine Modulation.

Authors:  Claudia Rangel-Barajas; George V Rebec
Journal:  J Huntingtons Dis       Date:  2016-12-15

3.  Levodopa-Responsive Chorea: A Review.

Authors:  Mark Farrenburg; Harsh V Gupta
Journal:  Ann Indian Acad Neurol       Date:  2020-02-25       Impact factor: 1.383
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.